EUVIMED · CrossrefJournal
Journal of Clinical and Translational Hepatology
ISSN 2310-8819 · Xia & He Publishing
Latest articles
Jaundice Is Associated with Intraoperative Hypotension, Suppressed Immune–endothelial NF-κB/EDN1 Signaling, and Impaired Vascular Cell Function
Astragaloside IV in Liver Fibrosis: Mechanistic Insights, Preclinical Evidence, and Translational Challenges
Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation
Interpreting the Association Between Hypertension and Extrahepatic Cancers in MASLD: Insights from NHANES
Residual Hepatitis B Burden Despite Declining Rates Across 21 Middle East and North Africa Countries, 1990–2023: Age Patterns and a Case Study of Oman
Gluten-free Diet and Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanisms and Therapeutic Potential
Three Latent Immune-metabolic Dimensions Improve Prediction of ACLF and Mortality in Acute Decompensation of Cirrhosis
UGT1A1 Mutations and Clinical Features in Hereditary Unconjugated Hyperbilirubinemia: A Chinese Cohort Study
Persistent Elevation of Alpha-fetoprotein in a Healthy Man Without Evidence of Malignancy: A Case Report and Focused Narrative Review
Myeloid-derived Suppressor Cells in Metabolic Dysfunction-associated Fatty Liver Disease
Clinical Insights Derived from Sequential Transarterial Chemoembolization after Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma
Palmatine Induces TNNT1 Ubiquitination and Degradation to Potentiate Ferroptosis Sensitivity in Hepatocellular Carcinoma
Lipid Metabolism-related lncRNA Model Identifies AC026412.3 as a Driver of Fatty Acid β-oxidation in Hepatocellular Carcinoma
Integrative Multi-omics and Machine Learning Reveal the Therapeutic Mechanisms of Juanyu-Xiaozhi Formula in Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatic Fibrosis via the AP-1/PPARγ/SCD1 Axis
Early Prediction of Non-recovery in Drug-induced Liver Injury by Integrating Genetic Variants and Clinical Variables: An Interpretable Machine Learning Approach
Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels
Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study
Molecular Basis and Clinical Significance of the High-risk Phenotype of Hepatitis B Virus Genotype C
qHBsAg Trajectories with Peg-IFNα-2b Add-on Therapy in Nucleos(t)ide Analog-experienced HBeAg-positive Chronic Hepatitis B
Comparative Efficacy of Promising Targets in the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Network Meta-analysis
Berberine Attenuates Hepatic Sinusoidal Obstruction Syndrome by Inhibiting Endothelial-mediated Neutrophil Recruitment and Activation
Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients
FN1 Knockout Inhibits Tumorigenesis but Promotes Lung Metastasis in Hepatocellular Carcinoma
The Role of Nitric Oxide in Chronic Liver Disease: A Review
Referral-spectrum Effect in Hypercupriuric Referrals for Suspected Wilson Disease: Diagnostic Implications for Ceruloplasmin and 24-hour Urinary Copper Excretion
Mineralocorticoid Receptor Antagonists for Liver Fibrosis: Potential Mechanisms and Research Progress
Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma
Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study
Expanding the Horizon: A Roadmap for Artificial Intelligence Integration in Metabolic Dysfunction-associated Steatotic Liver Disease
Advances in Precise Assessment of Portal Pressure in Porto-sinusoidal Vascular Disease
EUVIMED